NEW DELHI: As the work continues to develop an effective vaccine for COVID-19, the government on Saturday said two pan-India studies on the genome of the virus in India suggest it is genetically stable and has shown no major mutation.
There had been concerns in some quarters that any major mutation detected in the novel Coronavirus could hinder the development of an effective vaccine. However, some recent global studies have said the vaccines currently being developed for COVID-19 should not be affected by recent mutations.
Mutation typically refers to the property of a virus to change when it multiplies and the virus may develop some new strains after it replicates. In cases, the new strains tend to be less effective and therefore die out soon, while more powerful strains may lead to faster spread of the virus.
Meanwhile, India’s Covid caseload went past 74 lakh, while the number of people who have recuperated from the disease crossed 65 lakh pushing the recovery rate to 87.78 per cent, according to data updated by the Union Health Ministry on Saturday.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE
October 18 2020